Improved Postprandial Glucose With Inhaled Technosphere Insulin Compared With Insulin Aspart in Patients With Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Diabetes Technology and Therapeutics - United States

doi 10.1089/dia.2018.0200